Capsiderm

Quick links to important sections

Capsiderm

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Capsiderm

Quick Facts

Property Description
Active ingredient Capsaicin, Menthol (Levomenthol)
Form Topical Patch (Dermal-delivery system), Cream, Gel
Pharmacological class Counterirritant
Common use Localized relief for aches and stiffness
Origin Combination (Natural botanical + Terpenoid)

What Type of Medicine is Capsiderm?

Capsiderm is an Over-the-Counter (OTC) topical analgesic combination medication that belongs to the counterirritant pharmacological class. This class of ingredients is recognized for its capacity to produce a mild, localized surface irritation that distracts from deeper discomfort. The product is fundamentally designed as a non-systemic intervention, focusing its activity exclusively on the area of application. As a distinct feature of this combination, Capsiderm is often recognized in formulations specifically targeting musculoskeletal aches.


Active Ingredients and Origin of Capsiderm

The formulation contains the active ingredients Capsaicin and Menthol (Levomenthol). Capsaicin is a naturally-occurring alkaloid derived from chili peppers (Capsicum species), characterized by its specific chemical structure. Menthol is a terpenoid compound that can be either natural or synthesized. The medicine’s composition leverages this blend, which is clinically recognized as an effective combination for modifying local sensory perception. The combination is typically delivered through a base, such as a polymer adhesive matrix in the patch form or an emollient cream base in other preparations.


What is the General Purpose of Capsiderm's Dual Action?

The general purpose of Capsiderm is to help alleviate localized aches by actively modifying the user’s perception of discomfort at the application site. This dual action is achieved by Menthol providing an initial sensation of cooling and sensory distraction, while Capsaicin gradually causes a desensitization of local sensory nerves. The combined approach is recognized for its ability to affect pain-transmitting nerves. This provides a focused, external method of pain management that does not rely on systemic action.

What side effects are possible with Capsiderm?

Possible Side Effects and Safety Information

The official safety profile for Capsiderm, based on regulatory labeling for its active ingredients, is primarily structured around expected local application site reactions and documented systemic observations. The majority of observed adverse reactions are localized and typically self-limiting.

Frequency-Classified Adverse Reactions

The most frequently documented adverse reactions are associated with the application site and categorized based on incidence in clinical data:

Frequency Tier Examples of Documented Reactions
Very Common (ge 1/10) Application site pain, Application site erythema (redness)
Common (ge 1/100 to < 1/10) Application site pruritus (itching), Application site oedema (swelling), Burning sensation, Cough
Uncommon (ge 1/1,000 to < 1/100) Hypoesthesia (reduced sensation), Tachycardia (fast heart rate), Herpes zoster

Systemic Observations and Serious Adverse Reactions

Adverse reactions that affect other body systems, categorized by System-Organ Class, include Nervous System Disorders (e.g., temporary reductions in sensory function), Vascular Disorders (e.g., transient increases in blood pressure), and Respiratory Disorders.

Regulatory documentation also specifies serious safety events, which, while rare, are critical to the medicine's profile. These include documented application site burns (including second- and third-degree) and systemic Hypersensitivity reactions, such as anaphylaxis.

Population-Specific Safety Notes

The product is not recommended for use in children under 12 years of age. Safety during pregnancy is not established, but adverse effects are generally considered unlikely due to minimal systemic absorption. Safety statements also note that the burning sensation may increase with exposure to heat, such as after a bath or shower.

Overdose and Emergency Response

Overdose and when to seek help

Capsiderm's active ingredient is capsaicin, which is a potent irritant. Due to its nature as a topical agent, a systemic overdose is typically the result of accidental or excessive ingestion.

Documented Overdose Symptoms

Regulatory and scientific documentation reports that an acute overdose primarily affects the gastrointestinal (GI), respiratory, and cardiovascular systems. The documented presentation is often characterized by pronounced local irritation followed by systemic effects.

System Affected Clinical Manifestations (from regulatory context)
Gastrointestinal Severe burning sensation in the mouth and GI tract, nausea, vomiting, abdominal pain, and burning diarrhea.
Cardiovascular/Respiratory High intake levels may cause circulatory issues, including changes in blood pressure, cold sweats, dizziness, and potential respiratory distress.
Other Intense pain and burning on skin and mucous membranes, conjunctivitis, tearing, and respiratory irritation (e.g., coughing, bronchoconstriction) from exposure.

When to Seek Immediate Medical Help

The regulatory profile emphasizes that immediate emergency medical attention is required following any suspected or confirmed acute, high-level exposure or ingestion of the active ingredient. This is necessary even if symptoms appear mild initially, as systemic effects, particularly on the respiratory and circulatory systems, can develop rapidly. Removing the product and decontamination (e.g., washing affected skin/eyes) should be a first step, followed by professional medical evaluation. Ingestion of extremely high quantities has been associated with severe toxicity.

Therapeutic Uses of Capsiderm

What Capsiderm Treats: Main Uses and Benefits

Capsiderm is used in areas where short-term symptom management is appropriate for symptoms related to physical discomfort associated with the musculoskeletal system. The product is applied to help ease groups of symptoms related to physical discomfort in localized areas. The primary therapeutic areas focus on providing relief for specific musculoskeletal symptoms.

Scope of Symptom Relief

Capsiderm is relevant in contexts marked by increased discomfort or tension from minor aches and pains. This includes managing symptoms that interfere with daily comfort, such as those related to muscle strains, sprains, bruises, and episodic joint discomfort. The product is applied when symptoms interfere with daily functioning, and may assist with maintaining functional stability during periods of heightened symptoms.

“This approach is relevant when supportive symptom management is appropriate, and may assist with localized discomfort.”

It is commonly used across conditions presenting with acute episodes, or where symptoms are associated with physical overexertion or minor trauma. The application of the product in these settings may assist in easing the overall symptom load.


Quick Fact: Relief for Musculoskeletal Discomfort
Commonly used for Minor aches, stiffness, muscle strains, joint aches
Key benefit Provides symptomatic support to ease symptom burden
Typical context Acute episodes, post-exertion, recurrent stiffness
Focus Localized, non-systemic temporary relief

Regulatory References

  1. DailyMed (NIH/NLM) Drug Labeling

Eligibility and Restrictions for Use

Who can and cannot use Capsiderm?

The official eligibility profile for the Capsiderm topical patch is based on age, local application conditions, and known sensitivities, as defined in government regulatory labeling. This profile outlines who is permitted to use the medicine and who is prohibited or restricted.


Eligibility and Restrictions

Population Group Regulatory Status Restriction Details
Adults and Adolescents Permitted Use Approved for individuals 12 years of age and older.
Children Conditional Use Not recommended in children under 12 years old. Use requires consultation with a health professional, as safety is not established.
Damaged Skin Absolute Local Prohibition Must not be applied to skin that is broken, damaged, cut, infected, or irritated.
Hypersensitivity Contraindicated Use is strictly prohibited for individuals with a known allergy to Capsaicin, Menthol, or any other component.

Vulnerable Populations

Use during pregnancy or breastfeeding is classified as conditional use. Regulatory documents state that safety has not been established for these groups, necessitating a consultation with a health professional before use. Additionally, official labeling does not specify restrictions related to systemic organ functions, such as severe renal or hepatic impairment, due to the medicine's topical nature.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section addresses the interaction patterns for Capsiderm, based exclusively on restrictions and conditions documented in official government regulatory sources for this non-systemic topical counterirritant. The profile is primarily focused on localized interactions due to the minimal systemic absorption.

️ Interaction Scope Summary

Category Official Regulatory Status
Systemic Medicinal Products No systemic drug-drug interactions documented (e.g., no CYP enzyme or transporter interactions).
Medicinal Product Categories Other topical treatments.
Interaction-Related Restrictions External heat sources (heating pads, direct sunlight) and tight bandaging.
Timing-Based Rules Mandatory co-administration separation (must not be used on the same area of skin).

Official Interaction Statements

The regulatory profile for Capsiderm is defined by explicit constraints on local application and the surrounding physical environment.

  • Co-Administration Restriction: Official labeling specifies that the product must not be co-administered with any other topical treatment on the same area of skin. This serves as a mandatory local administration separation rule.
  • Environmental Prohibition: Application of external heat sources is strictly restricted. This includes the prohibition of using a heating pad or subjecting the treated area to direct sunlight, which are documented as local factors that can modify exposure and increase irritation.
  • Physical Restriction: Regulatory documents restrict the tight bandaging of the application site, as this physical action may result in an unintended change in local exposure and the related risk profile.

This interaction structure is entirely consistent with the product’s non-systemic classification and is focused on controlling localized effects and administration conditions as mandated by regulatory bodies.

Mechanism of Action

How Capsiderm Works: Mechanism of Action

The mechanism involves the active ingredient binding to and functionally activating the Transient Receptor Potential Vanilloid 1 (TRPV1) ion channel on peripheral sensory nerve endings. This interaction facilitates an influx of positive ions, initially causing nerve depolarization and action potential firing. However, this initial hyper-activation triggers a subsequent functional desensitization of the nociceptor, impairing the nerve's ability to transmit subsequent activating signals. This mechanism is key to reducing the excitability within the peripheral nociceptive system.

A parallel mechanistic domain involves influencing local blood vessel activity. The nerve activation and secondary components initiate a neurogenic cascade and cause local vasodilation, which is the widening of blood vessels. This results in increased blood flow and a distinct, transient warming sensation. The final action relies on this multi-component strategy that combines nerve desensitization with localized circulatory modulation, contributing to the overall dynamics of the drug's physiological effect profile.

Dosage and Administration Information

The usage protocol for Capsiderm, an over-the-counter topical analgesic, is based on established administration parameters. The approved method of delivery is topical application directly to the area of discomfort. Dosing is volumetric and localized, requiring the application of a thin layer of the cream or gel formulation, or the use of one patch per application site. This high-level instruction contrasts with systemic medications, where dosing is based on mass or weight.


The regimen dictates time-bound and intermittent use. Cream or gel formulations are applied no more than three to four times daily. For the patch formulation, applications are limited to three times per day, with each unit left on for no more than 8 hours. Adherence to a specific procedure is required: the product must only be administered to clean, dry, and intact skin. The instructions also prohibit the use of tight bandaging or the application of external heat sources over the treated area, which are key constraints to proper use.


Usage is confined to a short-term course. If symptoms continue or worsen after seven days of use, the instruction is to discontinue the product. For the pediatric population, the standard adult regimen is approved for children 12 years and over; however, use in children under 12 years of age must be preceded by consultation with a physician.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Capsiderm

Evidence for Use in Localized Joint Discomfort

Research has explored the single active ingredient, Capsaicin, in studies examining patient-reported experiences related to localized physical discomfort. These investigations primarily included short- to intermediate-term Randomized Controlled Trials (RCTs) and systematic reviews. The populations studied typically involved adults and older adults with localized discomfort, including those with diagnoses such as osteoarthritis of the knee or hand. Studies monitored outcomes related to physical discomfort and how these outcomes evolved in the observed populations.

Findings describe patterns of outcomes observed in the studies, based on measurements taken during the study period. Research examined measurements using standardized scales that focused on outcomes reflecting daily functioning or activity level. However, reported outcomes were often short-term, and the results apply only to the specific populations studied. The reported measurements of change varied in magnitude across the available research.

Evidence is limited for the specific dual-ingredient combination of Capsaicin and Menthol in this context. Furthermore, the follow-up durations were limited in many primary trials, meaning that long-term outcomes are not fully established.


Evidence for Use in Minor Musculoskeletal Aches and Strains

Research for the broader counterirritant class of ingredients, which includes both Menthol and Capsaicin, was evaluated in short-term RCTs and observational settings. These studies focused on adults presenting with conditions associated with acute or disruptive episodes, such as minor muscle strains or sprains. Research examined outcomes describing episodic or acute changes in localized tissue, often monitoring patient-reported outcomes describing perceived discomfort.

Studies report changes measured during the study period related to how symptoms evolved in the observed populations in the immediate time frames following application. Research examined changes measured during the study period, showing data patterns related to symptom intensity. This evidence contributes to understanding symptom patterns observed in the context of acute musculoskeletal events.

However, comparative evidence for the specific Capsaicin/Menthol combination for acute aches and strains remains limited. Available studies primarily focus on research exploring short-term symptom changes, and therefore data are still emerging regarding broader patterns of use. Some of the existing evidence is derived from trials where sample sizes were modest.


Study Design and Comparison Against Placebo

Most clinical research involving topical ingredients is structured as placebo-controlled studies. These are used in research examining symptom intensity or variability to determine how patient experiences differ when using an active ingredient versus an inactive product (a placebo). The goal of these study designs is to help contextualize how patients reported their experience when a topical product was applied to an area of concern. The evidence derived from these settings helps show what has been observed so far in group patterns.


Long-Term Studies and Follow-Up Duration

The majority of the available evidence is relevant in trials assessing short-term or episodic symptom patterns, as follow-up durations were limited in the primary research. The evidence contributes to the broader evidence landscape but provides limited insight into how symptoms evolve over extended time intervals. There is limited information for long-term outcomes, and long-term outcomes are not fully established.


Evidence in Special Populations

The research conducted to date primarily included general adult populations presenting with specific joint or muscle discomfort. Data for certain groups, such as children, pregnant individuals, or those with significant comorbid conditions, remain insufficient. While the available evidence contributes to understanding symptom patterns, the findings describe group patterns, not personal outcomes. Study results reflect the specific conditions under which they were conducted.


What Remains Uncertain About the Research Base

A key area where data are still emerging relates to the specific effects of the dual-ingredient blend of Capsaicin and Menthol, as much of the existing research focused on the ingredients individually. Comparative evidence is lacking for how this specific combination may interact across different outcomes. Additionally, the challenge of maintaining effective blinding in studies, due to the recognizable warming or cooling sensation caused by the active ingredients, means that certainty remains low in some comparative findings. Overall, research provides context but not individual predictions, and the evidence highlights what is known and what is still uncertain.

Key Studies & References

  1. DailyMed Drug Labeling for Topical Counterirritant Combination Products (Capsaicin/Menthol)
  2. Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (referencing topical analgesics)

Frequently Asked Questions (FAQ)

Common questions about Capsiderm (FAQ)


Q: Why do people say Capsiderm can help with discomfort?

Official documents describe the active ingredients' dual action. Menthol creates a cooling sensation that may help distract from discomfort. At the same time, Capsaicin works by causing a temporary desensitization of the local sensory nerves, which reduces their ability to transmit signals of discomfort in the applied area.


Q: How quickly does Capsiderm usually start working?

While the initial cooling sensation from Menthol may be noticed quickly, regulatory information indicates that for some products containing Capsaicin, it may take one to two weeks of consistent application to observe the intended effects. Individual experiences with onset time can vary.


Q: What is the difference between Capsiderm and other treatments for similar conditions?

Capsiderm is classified as a topical counterirritant. Its primary differentiating feature, according to official labeling, is the combination of its two active ingredients, Capsaicin and Menthol, which work together to modify local sensory perception in the applied area.


Q: Is Capsiderm safe to use if I have sensitive skin?

Official warnings note that common adverse reactions include application site pain and redness (erythema). Use is strictly prohibited if there is a known allergy or hypersensitivity to any component, according to official labeling.


Q: What should I do if the feeling from Capsiderm is too intense?

If the sensation is severe, the documented instruction for severe sensation is to discontinue use and consult a health professional, as advised in the product's official safety information. If the product accidentally contacts sensitive areas like the eyes, safety information advises that the area should be flushed with plenty of water.


Q: Can people with certain chronic conditions use Capsiderm?

Official labeling does not specify restrictions for the use of this topical non-systemic medication in relation to systemic chronic conditions, such as severe kidney or liver impairment.


Q: What is known about Capsiderm's effects on the nervous system?

The medicine's mechanism is described as involving a process of nerve desensitization in the localized area of application. Documented, temporary adverse reactions have included reductions in sensory function (known as hypoesthesia) in the nervous system.


Q: Does alcohol consumption affect the use of Capsiderm?

Due to the medicine’s classification as a topical and non-systemic product, official documents state there are no systemic drug-drug interactions with consumed alcohol documented in regulatory documents.


Q: Does Capsiderm have any connection to natural or herbal remedies?

One of the active ingredients, Capsaicin, is a naturally-occurring compound known as an alkaloid. It is derived from plants of the chili pepper (Capsicum) species.


Q: What happens if I forget to use Capsiderm for a day?

If a dose is missed, regulatory instructions are to apply it as soon as remembered. If it is close to the time of the next scheduled application, the missed dose should be skipped. Official guidance emphasizes that users should not double the dose to compensate for a missed application.


Q: What are the expectations for results after using Capsiderm for several weeks?

Official instructions limit use to a short-term course. Users are advised to discontinue the product if symptoms persist or worsen after seven days of use. Official research evidence on long-term outcomes is not fully established.


Q: What if I accidentally touch my eyes after applying Capsiderm?

Official safety information instructs users to avoid contact with the eyes and mucous membranes. If accidental contact occurs, safety information advises that the area should be immediately flushed with plenty of water.


Q: What does 'contraindications' mean for Capsiderm?

A contraindication is a specific condition or circumstance, such as a known allergy to an ingredient, that makes the use of the medicine prohibited or not recommended, as defined by official regulatory documents.


Q: Is Capsiderm intended to treat the root cause or just the feeling of discomfort?

Capsiderm is officially classified as a topical counterirritant. The medicine is designed to help alleviate localized aches by modifying the user’s perception of discomfort at the application site, which is a non-systemic function.


Q: Can I use heat or cold therapy while using Capsiderm?

Official labeling includes a strict prohibition on the application of external heat sources (such as heating pads) over the treated area. The use of cold therapy is not specified as a restriction in regulatory documents.


Q: Does Capsiderm affect blood pressure?

Documented adverse reactions that affect other body systems have included transient increases in blood pressure in some instances. This is a systemic observation documented within the medicine's safety profile.


Q: Are there any food or diet restrictions while using Capsiderm?

Due to the medication's topical, non-systemic classification, official documents report no known restrictions related to food or diet while using the product.


Q: How long does the effect of one application of Capsiderm last? (General formulation)

For the patch formulation, the unit is documented to be left on for no more than 8 hours. The cream or gel formulations are typically applied no more than three to four times daily, which supports the interval between applications, as defined in the official regimen.


Q: Is Capsiderm considered addictive?

Capsiderm is an Over-the-Counter (OTC) topical analgesic and is not classified as a controlled substance. Official regulatory documents do not associate its topical use with drug dependence or addiction.


Q: What types of interactions are commonly described in official documents for Capsiderm?

The documented interactions for this topical medicine are primarily localized. These include co-administration separation rules (avoiding use with other topicals on the same area), environmental prohibitions (avoiding external heat sources), and physical restrictions (avoiding tight bandaging).


How should Capsiderm be stored and disposed of?

Storage and Disposal Requirements for Capsiderm

Official regulatory documents define strict conditions for storing and disposing of Capsiderm (Capsaicin/Menthol) to maintain product stability.

Storage

The product must be stored at Controlled Room Temperature, defined as 20C to 25C (68F to 77F), with excursions allowed up to 30C. It must be stored in the original container and be protected from excessive moisture and direct sunlight. The labeling requires that the medicine be kept out of reach of children.

Disposal

Unused or expired product should be disposed of safely. Options include utilizing authorized drug take-back programs or following household trash disposal procedures. The procedure for household trash involves mixing the medicine with an unappealing substance, such as dirt or used coffee grounds, and sealing it in a container before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Capsiderm found in:

A-Z Index: